INTRODUCTION
Methicillin-resistant Staphylococcus aureus (MRSA) is the highly prevalent of hospital-associated and community-associated infections worldwide [1] . This has resulted in an increased use of vancomyin, which have been the treatment of choice for MRSA infection for decades. Unfortunately, this led worldwide to the development of S. aureus strains with reduced susceptibility to vancomycin [1] .
The first strain of vancomycin-intermediate S. aureus (VISA) and heterogeneous VISA (hVISA) was reported in Japan in 1997 [2] . Since then, clinical isolates of S. aureus with decreased susceptibility to vancomycin have been reported in many countries, including the United Satates [3, 4] , Canada [5] , China [6] , South Korea [6] , United Kingdom [7, 8] , Italy [9] , and France [10] , and their occurrence has become a major concern throughout the world. Additionally, in 2002, the first vancomycin-resistant S. aureus (VRSA) strain was reported in the Jung Wook Kim, et al. : Molecular Characteristics and Resistance Profiles of VISA 89
United States [11] . Thirty five cases of VRSA infection have been reported worldwide by May 2016, including 1 from Pakistan, 3 from Iran, 14 from the USA, 16 from India, and 1 from Portugal [12] [13] [14] .
Reduced susceptibility to vancomycin in S. aureus is complex and difficult to detect in clinical microbiology laboratories [15] . and VRSA was not detected [17] .
In this study, to update the previous nationwide surveillance data, we investigated the prevalence and resistance profiles of VISA strains among clinical isolates of S. aureus collected in 2007-2013. We also characterized the genotypes of these strains using diverse genotyping methods such as MLST, SCCmec typing, spa typing, and rep-PCR-based typing.
MATERIALS AND METHODS

Bacterial isolates
A total of 155,033 S. aureus isolates were collected from clinical samples at general and tertiary hospitals participating in a nationwide laboratory surveillance program for VISA/VRSA during the period of 12 weeks each year from 2007 and 2013.
MRSA was defined as S. aureus that grew on mannitol salt agar with 6 μg/mL oxacillin and confirmed by mecA gene PCR [17] .
Vancomycin agar screening and VISA confirmation test
Screening of MRSA with reduced susceptibility to vancomycin was performed using previously described [17] . A 10 μL drop of a 0.5 McFarland suspension was inoculated onto brain heart infusion agar supplemented with 4 μg/mL vancomycin (BHI-V4). After 24 and 48 h of incubation at 35 o C, plates were examined for growth. A positive BHI-V4 screen result for VISA was defined as growth of two or more colonies from one droplet.
VISA was finally confirmed by agar dilution, broth dilution and E-test methods with vancomycin minimum inhibitory concentrations (MIC) of ＞2 μg/mL. 
DNA extraction
Molecular typing
All VISA isolates were determined molecular types. Five typing methods, i.e., MLST, SCCmec typing, spa typing, agr typing, and diversilab typing were used in the present study. MLST was carried out by PCR amplification and sequencing of seven housekeeping genes (arc, aroE, glpF, gmk, pta, tpi and yqiL) by using primer pairs as previously described [18] . The allelic profiles and sequence types (STs) were assigned by the MLST web site (http://saureus.mlst.net/). The spa typing was performed as previously described [19, 20] . The spa types were determined by using Ridom SpaServer (http://spa.ridom.de/spatypes.shtml).
SCCmec types were determined by the multiplex PCR method [21] . Strains COL, N315, and MW2 were included as controls for SCCmec type I, II, and IV, respectively. The agr grouping was performed by multiplex PCR as previously described [22] .
For Diversilab (DL) typing, repetitive-sequence based PCR was performed using the DL Staphylococcus kit (bioMérieux, Marcy I'Etoile, France). The amplification products were separated using a DL DNA LabChip kit with microfluidic technology, as described previously [23] . The analysis was performed using DL software (version v.r.3.6). The data for each sample con- 
sisted of a dendrogram, a vertical gel image (band pattern), a graph of fluorescence corresponding to each band pattern, and a similarity matrix. The relatedness was determined by cluster analysis and guidelines provided by manufacturer. Isolates were considered identical where there was ＞95% similarity and no differences in bands.
Antimicrobial susceptibility testing
All VISA isolates were tested for susceptibility to 14
antibiotics. The disk diffusion method was used to test of susceptibility to 10 antibiotics, including cefazolin, clindamycin, er- (Table 3) .
A total of 4 STs were identified among the 76 VISA isolates (Table 3) . One isolate was novel type with allele profile 1-4-1-8-4-99-3 which is a single-locus variant of ST72. The (10) II (9), IV (1) II (9), I (1) Sputum (2), skin and soft tissue (2), fluid (2), pus (1), bone (1), lung PCD aspirate (1), others (1)* t9353 (5) II (5) II (5) Sputum (3), wound (1), bronchial aspirate (1) t601 (2) II (2) II (2) Sputum (1), pus (1) t264 (1) II (1) II (1) Blood (1) ST72 (12) t324 (10) IV (10) I (9), III (1) Pus (5), sputum (2), eye discharge (1), blood (1), others (1)* t901 (1) IV (1) I (1) Fluid (1) New type (1) IV (1) I (1) Others (1) ST239 (8) t037 (8) III (8) I (8) Skin and soft tissue (2), wound (2), pus (1), sputum (1), others (2)* Novel (1) t324 (1) IV (1) I (1) Wound (1) *Chemoport, percutaneous nephrostomy aspiration, tip, transtracheal aspirate. Abbreviation: PCD, percutaneous catheter drainage. Ten spa types were identified including t2460, t324, t002, t037, t9353, t286, t601, t264, and t901. The spa type for one isolate was not identified. The most predominant types were t2460 (44.7%, 34/76), followed by t324 (14.5%, 11/76), t002 (13.2%, 10/76), t037 (10.5%, 8/76), and t9353 (6.6%, 5/76).
Regarding agr groups, agr group II was predominant (67.1%, 51/76), and followed by agr group I (27.6%, 21/76), and agr group III (5.3%, 4/76).
We found that ST5-II-t2460, ST72-IV-t324, and ST239-III-t037 were common strains of VISA isolates. These clones displayed different antimicrobial resistance profiles depending on the genotypes (Table 4) . ST5-II-t2460, ST5-II-t002, ST5-II-t9353 and ST239-III-t037 strains were similarly resistant to most of the antimicrobial agents tested except rifampicin, and tigecycline, and trimethoprim-sulfamethoxazole. ST5-II strains were more resistant to rifampicin and tigecycline than ST239-III-t037 strains. ST239-III-t037 strains more resistant to trimethoprim-sulfamethoxazole than ST5-II-t2460, ST5-II-t002 and ST5-II-t9353 strains. ST72-IV-t324 strains were susceptible to all of the antimicrobial agents tested except erythromycin and daptomycin. ST1-IV-t286 strains were susceptible to most of the agents tested except erythromycin and gentimicin. ST5, ST239, and ST72 strains had similarly rate of resistance to daptomycin.
Among ST5-II-t2460 clones with nonsuceptible to daptomycin, two strains showed nonsuseptible to tigecycline simultaneously.
All of the 76 VISA isolates were susceptible to linezolid and quinupristin-dalfopristin (Table 4) .
Diversilab typing of the 76 VISA isolates revealed 4 distinct clusters (P1 to 4) and 1 singleton pattern (P5) (Fig. 1) . The most common clones were P4 (ST5-SCCmecII, n=52), followed by P2 (ST72-SCCmecIV, n=12), P3 (ST239-SCCmecIII, n=8), P1
(ST1-SCCmecIV, n=3), and P5 (new-SCCmecIV, n=1). When comparisons were made to the DL MRSA library, it was found that P4 and P3 were closely related to the USA100 and Brazilian cluster, respectively. P1 showed 88% similarity with the CA-MRSA USA400 cluster. P2 and P5 did not match any
isolates in the Diversilab library.
DISCUSSION
In the present study, during a seven-year period in Thailand, and 1.9% in Taiwan [24] . The result from the ANSORP study was higher than our two surveillance data. This differences in prevalence may be due to the period of the study or sample size. Additionally, a recent systematic review summarized 91 published studies from throughout the world comparing of incidence of S. aureus with reduced susceptibility to vancomycin (hVISA/VISA) in different study year, locations, and types of clinical samples [25] . The prevalence of hVISA could be attributed to several factors, including differences in test strategies, geographic regions, and study populations.
In the present study, we determined the proportion of VISA isolates evolved from MRSA, yet several studies for the preva-lence of hVISA/VISA from MSSA were reported. Hu et al. [26] reported that the proportion of hVISA among MSSA isolates was 4.1% in 2007-2010 period and increased significantly year-by-year in Northeast China. Liu and Chambers [27] found that the prevalence of hVISA was 0.05% in 1,868 MSSA isolates. Additionally, seven isolates (0.3%) of 2,300 S. aureus
were MSSA-hVISA in French hospital [10] and 2 isolates of 171 S. aureus were MSSA-VISA in Iran [28] . This suggests that it is as important to detect reduced vancomycin susceptibility in MSSA isolates as in MRSA, and there is an alarming need to pay attention to the occurrence of MSSA-hVISA/VISA.
Many studies have concerned on VISA strains isolated from blood, whereas in this study, we identified VISA strains from diverse sources, such as sputum, pus, wound, blood, skin and soft tissue, and others. Therefore, we recommend that S. aureus
isolates from diverse sources should be tested for reduced vancomycin susceptibility to prevent the emergence and spread of vancomycin resistance.
The results of molecular typing showed that ST5-SCCmecII (68.4%) was predominant clone, followed by ST72-SCCmecIVt324 (15.8%), ST239-SCCmecIII-t037 (10.5%), ST1-SCCmecIVt286 (3.9%). Interestingly, the proportion of ST239-SCCmecIII clones was reduced, while ST5-SCCmecII clones was increased compared with previous surveillance data [17] . Because of this change, ST72-SCCmecIV was the second predominant clone. In recent year, community-associated MRSA (CA-MRSA) has emerged as an important cause of infection with geographical differences among strains: ST1 (USA400) and ST8 (USA300) exist in North America, ST80 is found in Europe, ST59 is found in the Asia-Pacific region and ST30 is noted worldwide [29, 30] .
The ST72 which is major CA-MRSA clone in South Korea is distinct from those that have spread throughout Asia (ST30, ST59, and ST338) or internationally [30] . The Korean CA-MRSA strain has emerged in the community and has recently been spreading in healthcare settings [31, 32] . The ST72 may play a role as revolving door that spread of multidrug resistant bacteria both community and hospital. Therefore, it suggests that continuously molecular surveillance of VISA is needed. 
